BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 34257601)

  • 21. The Change of Systemic Immune-Inflammation Index Independently Predicts Survival of Colorectal Cancer Patients after Curative Resection.
    Chen Q; Wu H; Guo X; Gu K; Wang W; Chen X; Ji S; Yang H; Zhu J
    Mediators Inflamm; 2020; 2020():4105809. PubMed ID: 33293896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection.
    Diao P; Wu Y; Li J; Zhang W; Huang R; Zhou C; Wang Y; Cheng J
    J Transl Med; 2018 Dec; 16(1):365. PubMed ID: 30563540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer.
    Nakamoto S; Ohtani Y; Sakamoto I; Hosoda A; Ihara A; Naitoh T
    Tohoku J Exp Med; 2023 Nov; 261(3):229-238. PubMed ID: 37673651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor.
    Xie QK; Chen P; Hu WM; Sun P; He WZ; Jiang C; Kong PF; Liu SS; Chen HT; Yang YZ; Wang D; Yang L; Xia LP
    J Transl Med; 2018 Oct; 16(1):273. PubMed ID: 30286769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.
    Yang J; Guo X; Wang M; Ma X; Ye X; Lin P
    Sci Rep; 2017 Dec; 7(1):17166. PubMed ID: 29215037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
    Mercier J; Voutsadakis IA
    J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients.
    Holub K; Biete A
    Clin Transl Oncol; 2019 Jul; 21(7):836-844. PubMed ID: 30470994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein/albumin ratio predicts survival after curative surgery in elderly patients with colorectal cancer.
    Tamai K; Okamura S; Makino S; Yamamura N; Fukuchi N; Ebisui C; Inoue A; Yano M
    Updates Surg; 2022 Feb; 74(1):153-162. PubMed ID: 33677820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Low Neutrophil to Lymphocyte Ratio Before Preoperative Chemotherapy Predicts Good Outcomes After the Resection of Colorectal Liver Metastases.
    Mao R; Zhao JJ; Bi XY; Zhang YF; Li ZY; Huang Z; Zhou JG; Zhao H; Cai JQ
    J Gastrointest Surg; 2019 Mar; 23(3):563-570. PubMed ID: 30066069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.
    Tang H; Li B; Zhang A; Lu W; Xiang C; Dong J
    PLoS One; 2016; 11(7):e0159447. PubMed ID: 27427969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer.
    Zhou ZQ; Pang S; Yu XC; Xue Q; Jiang HY; Liang XJ; Liu L
    Curr Med Sci; 2018 Oct; 38(5):798-808. PubMed ID: 30341514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
    Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
    Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Huang T; Zhang H; Zhao Y; Li Y; Wang G; Zhang Y; Guo D; Ji S; Sun Z
    Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.